A Polygenic Score for Type 2 Diabetes Improves Risk Stratification Beyond Current Clinical Screening Factors in an Ancestrally Diverse Sample

Por James R. Ashenhurst, Olga V. Sazonova, Olivia Svrchek, Stacey Detweiler, Ryosuke Kita, Liz Babalola, Matthew McIntyre, Stella Aslibekyan, Pierre Fontanillas, Suyash Shringarpure, 23andMe Research Team, Jeffrey D. Pollard, Bertram L. Koelsch
Publicado em 2022-04-01